Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Adenosine A1 and A2A Receptors in Sleep Disorders: Mechanisms and Therapeutic Implications

  • Hye Jin Jee (Department of Pharmacy, Ajou University) ;
  • Cherin Youn (Department of Pharmacy, Ajou University) ;
  • Haeun Lee (Department of Pharmacy, Ajou University) ;
  • Yi-Sook Jung (Department of Pharmacy, Ajou University)
  • Received : 2026.03.26
  • Accepted : 2026.04.10
  • Published : 2026.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Sleep-wake regulation is controlled by circadian and homeostatic processes, with adenosine acting as a key molecular mediator of homeostatic sleep pressure. Extracellular adenosine accumulates during wakefulness as a result of neuronal energy metabolism, particularly in the basal forebrain, and declines during recovery sleep, thereby reflecting the physiological need for sleep. The sleep-promoting effects of adenosine are mediated primarily by two G protein-coupled receptor subtypes, the adenosine A1 receptor and the adenosine A2A receptor. The adenosine A1 receptor, coupled to inhibitory Gi/o proteins and widely expressed in the cortex, hippocampus, thalamus, and basal forebrain, suppresses wake-promoting neuronal activity and facilitates slow-wave activity during non-rapid eye movement sleep. In contrast, the adenosine A2A receptor, coupled to stimulatory Golf proteins and enriched in the striatum and nucleus accumbens, promotes sleep by activating neurons in the preoptic hypothalamus and engaging the indirect basal ganglia pathway. Despite these well-established roles, the contributions of dysregulation of the adenosine A1 receptor and the adenosine A2A receptor to specific sleep disorders remain incompletely understood. This review examines how signaling of the adenosine A1 receptor and the adenosine A2A receptor is altered in insomnia, obstructive sleep apnea, narcolepsy, and restless legs syndrome, and evaluates the therapeutic potential of receptor-selective strategies for adenosine receptor-targeted treatment.

Keywords

Acknowledgement

This research was supported by the GRRC program of Gyeonggi province (GRRCAjou2023-B01).

References

  1. Benjafield, A. V., Ayas, N. T., Eastwood, P. R., Heinzer, R., Ip, M. S. M., Morrell, M. J., Nunez, C. M., Patel, S. R., Penzel, T., Pépin, J. L., Peppard, P. E., Sinha, S., Tufik, S., Valentine, K. and Malhotra, A. (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir. Med. 7, 687-698. https://doi.org/10.1016/S2213-2600(19)30198-5
  2. Bjorness, T. E. and Greene, R. W. (2009) Adenosine and sleep. Curr. Neuropharmacol. 7, 238-245. https://doi.org/10.2174/157015909789152182
  3. Bjorness, T. E., Kelly, C. L., Gao, T., Poffenberger, V. and Greene, R. W. (2009) Control and function of the homeostatic sleep response by adenosine A1 receptors. J. Neurosci. 29, 1267-1276. https://doi.org/10.1523/JNEUROSCI.2942-08.2009
  4. Borbély, A. A. (1982) A two process model of sleep regulation. Hum. Neurobiol. 1, 195-204.
  5. Borbély, A. A., Daan, S., Wirz-Justice, A. and Deboer, T. (2016) The two-process model of sleep regulation: a reappraisal. J. Sleep Res. 25, 131-143. https://doi.org/10.1111/jsr.2016.25.issue-2
  6. Broström, A., Alimoradi, Z., Lind, J., Ulander, M., Lundin, F. and Pakpour, A. (2023) Worldwide estimation of restless legs syndrome: a systematic review and meta-analysis of prevalence in the general adult population. J. Sleep Res. 32, e13783. https://doi.org/10.1111/jsr.v32.3
  7. Carley, D. W., Hagan, R. M., Sheehan, M., Trbovic, S., Thai, T. and Radulovacki, M. (1997) Adenosine A1 receptor agonist GR79236 suppresses apnea during all sleep stages in the rat. Sleep 20, 1093-1098. https://doi.org/10.1093/sleep/20.12.1093
  8. Chikahisa, S. and Sei, H. (2011) The role of ATP in sleep regulation. Front. Neurol. 2, 87.
  9. Coelho, J. E., Rebola, N., Fragata, I., Ribeiro, J. A., de Mendonça, A. and Cunha, R. A. (2006) Hypoxia-induced desensitization and internalization of adenosine A1 receptors in the rat hippocampus. Neuroscience 138, 1195-1203. https://doi.org/10.1016/j.neuroscience.2005.12.012
  10. Dunwiddie, T. V. and Masino, S. A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31-55. https://doi.org/10.1146/neuro.2001.24.issue-1
  11. Earley, C. J., Uhl, G. R., Clemens, S. and Ferré, S. (2017) Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation. Sleep Med. 31, 71-77. https://doi.org/10.1016/j.sleep.2016.06.003
  12. Fang, T., Dong, H., Xu, X. H., Yuan, X. S., Chen, Z. K., Chen, J. F., Qu, W. M. and Huang, Z. L. (2017) Adenosine A(2A) receptor mediates hypnotic effects of ethanol in mice. Sci. Rep. 7, 12678.
  13. Ferre, S., Diamond, I., Goldberg, S. R., Yao, L., Hourani, S. M., Huang, Z. L., Urade, Y. and Kitchen, I. (2007) Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog. Neurobiol. 83, 332-347. https://doi.org/10.1016/j.pneurobio.2007.04.002
  14. Ferre, S., Garcia-Borreguero, D., Allen, R. P. and Earley, C. J. (2019) New insights into the neurobiology of restless legs syndrome. Neuroscientist 25, 113-125. https://doi.org/10.1177/1073858418791763
  15. Ferre, S., Quiroz, C., Guitart, X., Rea, W., Seyedian, A., Moreno, E., Casado-Anguera, V., Diaz-Rios, M., Casado, V., Clemens, S., Allen, R. P., Earley, C. J. and Garcia-Borreguero, D. (2017) Pivotal role of adenosine neurotransmission in restless legs syndrome. Front. Neurosci. 11, 722.
  16. Ferre, S., Sarasola, L. I., Quiroz, C. and Ciruela, F. (2023) Presynaptic adenosine receptor heteromers as key modulators of glutamatergic and dopaminergic neurotransmission in the striatum. Neuropharmacology 223, 109329. https://doi.org/10.1016/j.neuropharm.2022.109329
  17. Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A. and Zvartau, E. E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83-133. https://doi.org/10.1016/S0031-6997(24)01396-6
  18. Gao, Z., Guan, J., Yin, S. and Liu, F. (2024) The role of ATP in sleepwake regulation: in adenosine-dependent and -independent manner. Sleep Med. 119, 147-154. https://doi.org/10.1016/j.sleep.2024.04.031
  19. Garcia-Borreguero, D., Garcia-Malo, C., Granizo, J. J. and Ferré, S. (2021) A randomized, placebo-controlled crossover study with dipyridamole for restless legs syndrome. Mov. Disord. 36, 2387-2392. https://doi.org/10.1002/mds.v36.10
  20. Garcia-Borreguero, D., Guitart, X., Garcia Malo, C., Cano-Pumarega, I., Granizo, J. J. and Ferré, S. (2018) Treatment of restless legs syndrome/Willis-Ekbom disease with the non-selective ENT1/ENT2 inhibitor dipyridamole: testing the adenosine hypothesis. Sleep Med. 45, 94-97. https://doi.org/10.1016/j.sleep.2018.02.002
  21. Gulia, K. K. (2012) Dynamism in activity of the neural networks in brain is the basis of sleep-wakefulness oscillations. Front. Neurol. 3, 38. https://doi.org/10.3389/fneur.2012.00038
  22. Heitzmann, D., Buehler, P., Schweda, F., Georgieff, M., Warth, R. and Thomas, J. (2016) The in vivo respiratory phenotype of the adenosine A1 receptor knockout mouse. Respir. Physiol. Neurobiol. 222, 16-28. https://doi.org/10.1016/j.resp.2015.11.005
  23. Hersey, M. and Tanda, G. (2024) Modafinil, an atypical CNS stimulant? Adv. Pharmacol. 99, 287-326. https://doi.org/10.1016/bs.apha.2023.10.006
  24. Hong, Z. Y., Huang, Z. L., Qu, W. M., Eguchi, N., Urade, Y. and Hayaishi, O. (2005) An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J. Neurochem. 92, 1542-1549. https://doi.org/10.1111/jnc.2005.92.issue-6
  25. Huang, L., Zhu, W., Li, N., Zhang, B., Dai, W., Li, S. and Xu, H. (2024) Functions and mechanisms of adenosine and its receptors in sleep regulation. Sleep Med. 115, 210-217. https://doi.org/10.1016/j.sleep.2024.02.012
  26. Irwin, M. R. (2019) Sleep and inflammation: partners in sickness and in health. Nat. Rev. Immunol. 19, 702-715. https://doi.org/10.1038/s41577-019-0190-z
  27. Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Giménez-Llort, L., Escorihuela, R. M., Fernández-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.-J., Hårdemark, A., Betsholtz, C., Herlenius, E. and Fredholm, B. B. (2001) Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U. S. A. 98, 9407-9412. https://doi.org/10.1073/pnas.161292398
  28. Kalinchuk, A. V., McCarley, R. W., Porkka-Heiskanen, T. and Basheer, R. (2010) Sleep deprivation triggers inducible nitric oxide-dependent nitric oxide production in wake-active basal forebrain neurons. J. Neurosci. 30, 13254-13264. https://doi.org/10.1523/JNEUROSCI.0014-10.2010
  29. Kim, S., Jee, H. J., Park, J. Y., Bae, S. H., Kim, S. H., Kim, E., Lee, S. and Jung, Y. S. (2024) Hypnotic effect of AR-001 through adenosine A(1) receptor. Eur. J. Pharmacol. 981, 176847.
  30. Kim, T. H., Custodio, R. J., Cheong, J. H., Kim, H. J. and Jung, Y. S. (2019) Sleep promoting effect of luteolin in mice via adenosine A1 and A2A receptors. Biomol. Ther. (Seoul) 27, 584-590. https://doi.org/10.4062/biomolther.2019.149
  31. Kumar, S., Rai, S., Hsieh, K. C., McGinty, D., Alam, M. N. and Szymusiak, R. (2013) Adenosine A(2A) receptors regulate the activity of sleep regulatory GABAergic neurons in the preoptic hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R31-41. https://doi.org/10.1152/ajpregu.00402.2012
  32. Lazarus, M., Chen, J. F., Huang, Z. L., Urade, Y. and Fredholm, B. B. (2019a) Adenosine and sleep. Handb. Exp. Pharmacol. 253, 359-381. https://doi.org/10.1007/978-3-030-11272-1
  33. Lazarus, M., Oishi, Y., Bjorness, T. E. and Greene, R. W. (2019b) Gating and the need for sleep: dissociable effects of adenosine A(1) and A(2A) receptors. Front. Neurosci. 13, 740. https://doi.org/10.3389/fnins.2019.00740
  34. Lee, D. H., Jee, H. J. and Jung, Y. S. (2024) β-Lapachone exerts hypnotic effects via adenosine A(1) receptor in mice. Biomol. Ther. (Seoul) 32, 531-539. https://doi.org/10.4062/biomolther.2024.106
  35. Lee, K. B., Latif, S. and Kang, Y. S. (2023) Differences in neurotransmitters level as biomarker on sleep effects in dementia patients with insomnia after essential oils treatment. Biomol. Ther. (Seoul) 31, 298-305. https://doi.org/10.4062/biomolther.2023.014
  36. Li, X. C., Hong, F. F., Tu, Y. J., Li, Y. A., Ma, C. Y., Yu, C. Y., Fang, L., Chen, J. Y., Li, Z. L., Bao, S. J., Zhang, Z. L., Ying, H. Y., Gyabaah, A. T., Hu, S. Y., Shao, G. H. and Cai, X. H. (2022) Blockade of adenosine A(2A) receptor alleviates cognitive dysfunction after chronic exposure to intermittent hypoxia in mice. Exp. Neurol. 350, 113929.
  37. Lin, Y., Roy, K., Ioka, S., Otani, R., Amezawa, M., Ishikawa, Y., Cherasse, Y., Kaushik, M. K., Klewe-Nebenius, D., Zhou, L., Yanagisawa, M., Oishi, Y., Saitoh, T. and Lazarus, M. (2023) Positive allosteric adenosine A(2A) receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice. Front. Pharmacol. 14, 1138666.
  38. Liu, C., Cao, Y., Malhotra, A. and Ling, L. (2011) Sleep fragmentation attenuates the hypercapnic (but not hypoxic) ventilatory responses via adenosine A1 receptors in awake rats. Respir. Physiol. Neurobiol. 175, 29-36. https://doi.org/10.1016/j.resp.2010.09.003
  39. Liu, Z. W. and Gao, X. B. (2007) Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect. J. Neurophysiol. 97, 837-848. https://doi.org/10.1152/jn.00873.2006
  40. Ma, N., Liu, P., Li, N., Hu, Y. and Kang, L. (2025) Exploring the pharmacological mechanisms for alleviating OSA: adenosine A2A receptor downregulation of the PI3K/Akt/HIF‑1 pathway (review). Biomed. Rep. 22, 21.
  41. Mann, G. S., Ramakrishnan, M., Pakkam, M. L., Sufiyan, N., Kukadiya, R. and Girigosavi, K. B. (2026) An updated systematic review and meta-analysis of modafinil for excessive daytime sleepiness in narcolepsy. Sleep Med. X 11, 100185.
  42. Martinez-Gallego, I. and Rodriguez-Moreno, A. (2025) Adenosine and cortical plasticity. Neuroscientist 31, 47-64. https://doi.org/10.1177/10738584241236773
  43. Minzenberg, M. and Carter, C. (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33, 1477-1502. https://doi.org/10.1038/sj.npp.1301534
  44. Mochizuki, T., Crocker, A., McCormack, S., Yanagisawa, M., Sakurai, T. and Scammell, T. E. (2004) Behavioral state instability in orexin knock-out mice. J. Neurosci. 24, 6291-6300. https://doi.org/10.1523/JNEUROSCI.0586-04.2004
  45. Morin, C. M. and Jarrin, D. C. (2022) Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med. Clin. 17, 173-191. https://doi.org/10.1016/j.jsmc.2022.03.003
  46. Murillo-Rodriguez, E., Liu, M., Blanco-Centurion, C. and Shiromani, P. J. (2008) Effects of hypocretin (orexin) neuronal loss on sleep and extracellular adenosine levels in the rat basal forebrain. Eur. J. Neurosci. 28, 1191-1198. https://doi.org/10.1111/ejn.2008.28.issue-6
  47. Oishi, Y., Huang, Z. L., Fredholm, B. B., Urade, Y. and Hayaishi, O. (2008) Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc. Natl. Acad. Sci. U. S. A. 105, 19992-19997. https://doi.org/10.1073/pnas.0810926105
  48. Patel, D., Steinberg, J. and Patel, P. (2018) Insomnia in the elderly: a review. J. Clin. Sleep Med. 14, 1017-1024. https://doi.org/10.5664/jcsm.7172
  49. Peng, W., Wu, Z., Song, K., Zhang, S., Li, Y. and Xu, M. (2020) Regulation of sleep homeostasis mediator adenosine by basal forebrain glutamatergic neurons. Science 369, eabb0556. https://doi.org/10.1126/science.abb0556
  50. Porkka-Heiskanen, T., Alanko, L., Kalinchuk, A. and Stenberg, D. (2002) Adenosine and sleep. Sleep Med. Rev. 6, 321-332. https://doi.org/10.1053/smrv.2001.0201
  51. Porkka-Heiskanen, T., Strecker, R. E. and McCarley, R. W. (2000) Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 99, 507-517. https://doi.org/10.1016/S0306-4522(00)00220-7
  52. Porkka-Heiskanen, T., Strecker, R. E., Thakkar, M., Bjorkum, A. A., Greene, R. W. and McCarley, R. W. (1997) Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 276, 1265-1268. https://doi.org/10.1126/science.276.5316.1265
  53. Quiroz, C., Gulyani, S., Ruiqian, W., Bonaventura, J., Cutler, R., Pearson, V., Allen, R. P., Earley, C. J., Mattson, M. P. and Ferré, S. (2016) Adenosine receptors as markers of brain iron deficiency: implications for Restless Legs Syndrome. Neuropharmacology 111, 160-168. https://doi.org/10.1016/j.neuropharm.2016.09.002
  54. Reichert, C. F., Deboer, T. and Landolt, H.-P. (2022) Adenosine, caffeine, and sleep–wake regulation: state of the science and perspectives. J. Sleep Res. 31, e13597. https://doi.org/10.1111/jsr.v31.4
  55. Ren, C. Y., Rao, J. X., Zhang, X. X., Zhang, M., Xia, L. and Chen, G. H. (2021) Changed signals of blood adenosine and cytokines are associated with parameters of sleep and/or cognition in the patients with chronic insomnia disorder. Sleep Med. 81, 42-51. https://doi.org/10.1016/j.sleep.2021.02.005
  56. Rogers, A. E. and Dreher, H. M. (2002) Narcolepsy. Nurs. Clin. North Am. 37, 675-692. https://doi.org/10.1016/S0029-6465(02)00035-X
  57. Saper, C. B. and Fuller, P. M. (2017) Wake-sleep circuitry: an overview. Curr. Opin. Neurobiol. 44, 186-192. https://doi.org/10.1016/j.conb.2017.03.021
  58. Satoh, S., Matsumura, H., Koike, N., Tokunaga, Y., Maeda, T. and Hayaishi, O. (1999) Region-dependent difference in the sleeppromoting potency of an adenosine A2A receptor agonist. Eur. J. Neurosci. 11, 1587-1597. https://doi.org/10.1046/j.1460-9568.1999.00569.x
  59. Sattin, A. and Rall, T. W. (1970) The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. Mol. Pharmacol. 6, 13-23. https://doi.org/10.1016/S0026-895X(25)15197-3
  60. Scammell, T. E. (2015) Narcolepsy. N. Engl. J. Med. 373, 2654-2662. https://doi.org/10.1056/NEJMra1500587
  61. Scammell, T. E., Gerashchenko, D. Y., Mochizuki, T., McCarthy, M. T., Estabrooke, I. V., Sears, C. A., Saper, C. B., Urade, Y. and Hayaishi, O. (2001) An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 107, 653-663. https://doi.org/10.1016/S0306-4522(01)00383-9
  62. Senaratna, C. V., Perret, J. L., Lodge, C. J., Lowe, A. J., Campbell, B. E., Matheson, M. C., Hamilton, G. S. and Dharmage, S. C. (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med. Rev. 34, 70-81. https://doi.org/10.1016/j.smrv.2016.07.002
  63. Sims, R. E., Wu, H. H. and Dale, N. (2013) Sleep-wake sensitive mechanisms of adenosine release in the basal forebrain of rodents: an in vitro study. PLoS One 8, e53814. https://doi.org/10.1371/journal.pone.0053814
  64. Szabadi, E. (2025) Functional neuroanatomy of dopaminergic arousal systems: implications for the wake-promoting effect of psychostimulants, with particular reference to modafinil. Front. Neuroanat. 19, 1670564. https://doi.org/10.3389/fnana.2025.1670564
  65. Thakkar, M. M., Engemann, S. C., Walsh, K. M. and Sahota, P. K. (2008) Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 153, 875-880. https://doi.org/10.1016/j.neuroscience.2008.01.017
  66. Thakkar, M. M., Winston, S. and McCarley, R. W. (2003) A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain. J. Neurosci. 23, 4278-4287. https://doi.org/10.1523/JNEUROSCI.23-10-04278.2003
  67. Trincavelli, M. L., Daniele, S. and Martini, C. (2010) Adenosine receptors: what we know and what we are learning. Curr. Top. Med. Chem. 10, 860-877. https://doi.org/10.2174/156802610791268756
  68. Urry, E. and Landolt, H. P. (2015) Adenosine, caffeine, and performance: from cognitive neuroscience of sleep to sleep pharmacogenetics. Curr. Top. Behav. Neurosci. 25, 331-366. https://doi.org/10.1007/978-3-662-46878-4
  69. van Calker, D., Müller, M. and Hamprecht, B. (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33, 999-1005. https://doi.org/10.1111/jnc.1979.33.issue-5
  70. Zhang, Y., Cao, H., Qiu, X., Xu, D., Chen, Y., Barnes, G. N., Tu, Y., Gyabaah, A. T., Gharbal, A., Peng, C., Cai, J. and Cai, X. (2020) Neuroprotective effects of adenosine A1 receptor signaling on cognitive impairment induced by chronic intermittent hypoxia in mice. Front. Cell. Neurosci. 14, 202.